Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, People's Republic of China.
Department of Surgery, Beijing Zhanlanlu Hospital, Beijing, 100044, People's Republic of China.
Mol Cell Biochem. 2019 Jul;457(1-2):191-199. doi: 10.1007/s11010-019-03523-w. Epub 2019 May 9.
GATA1, a member of the GATA transcription factor family, was reported to play a role in development and progression of erythroid cells and breast cancer cells. However, the role of GATA1 in colorectal cancer (CRC) is unknown. Here, we demonstrate that GATA1 was upregulated in CRC tissues compared with normal tissues, and predicted poor clinical outcome in CRC. Biological functional analyses showed that GATA1 knockdown decreased CRC cells proliferation, migration and invasion, and regulated the process of epithelial-mesenchymal transition (EMT). Moreover, silencing of GATA1 suppressed colorectal tumor growth in nude mice. Mechanistically, GATA1 overexpression significantly increased the activity of PI3K/AKT signaling pathway in CRC cells. These data provide insight into the important role of GATA1 in CRC progression and suggest that GATA1 is a potential therapeutic target for CRC.
GATA1 是 GATA 转录因子家族的成员,据报道在红细胞和乳腺癌细胞的发育和进展中发挥作用。然而,GATA1 在结直肠癌(CRC)中的作用尚不清楚。在这里,我们证明与正常组织相比,GATA1 在 CRC 组织中上调,并预测 CRC 的临床预后不良。生物学功能分析表明,GATA1 敲低可降低 CRC 细胞的增殖、迁移和侵袭,并调节上皮-间充质转化(EMT)过程。此外,沉默 GATA1 可抑制裸鼠结直肠肿瘤的生长。机制上,GATA1 的过表达显著增加了 CRC 细胞中 PI3K/AKT 信号通路的活性。这些数据深入了解了 GATA1 在 CRC 进展中的重要作用,并表明 GATA1 是 CRC 的一个潜在治疗靶点。